NCT07395193Completed
Comparative Evaluation of BiZact™, Coblation, and Bipolar Tonsillectomy Techniques
A Prospective Observational Study Comparing BiZact™, Coblation, and Bipolar Tonsillectomy Techniques
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
This prospective, non-randomized observational study compared the surgical outcomes of BiZact™, Coblation, and Bipolar tonsillectomy techniques in pediatric and adult patients. Operative efficiency, postoperative pain, recovery parameters, postoperative bleeding, and device-related costs were evaluated.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 27 Jan 2026
- Start date
- 29 Nov 2024
- Primary completion date
- 29 Sept 2025
- Lead sponsor
- Medicana Bursa Hospital
- NCT number
- NCT07395193
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 29 Nov 2024 to the primary completion date, 29 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known coagulation disorders
- Presence of craniofacial syndromes
Other
- Presence of peritonsillar abscess
- Incomplete follow-up data
Who the study is looking for
- Age between 5 and 40 years
- Undergoing tonsillectomy
- Indication for surgery due to recurrent tonsillitis or obstructive sleep-related symptoms
Age in the registry: 5 years to 40 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medicana Bursa Hospital Coordinator of this site? Confirm its status | Nilufer | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.